Tomotake Morita

USPTO Granted Patents = 8 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 5(Granted Patents)

Location History:

Tsukuba, JP (2021)
Ibaraki, JP (2011 - 2023)

Company Filing History:

7 out of 1,714

National Institute of Advanced Industrial Science and Technology

Toyo Boseki Kabushiki Kaisha

patents

5. 1 out of 24

Sumitomo Forestry Co., Ltd.

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297473 - Production of monoacyl MEL (2025-05-13),

2. 12241106 - Biosurfactant-producing recombinant microorganism (2025-03-04),

3. 12173347 - Technique for controlling molecular weight of PHA copolymer produced by halobacterium (2024-12-24),

4. 11732236 - Method for producing novel microorganisms and ergothioneine (2023-08-22),

5. 11535717 - Ionic composite material including lignin sulfonic acid and E-polylysine as components (2022-12-27),

6. 11098288 - D-type amino acid dehydrogenase (2021-08-24),

7. 10927354 - D-type amino acid dehydrogenase (2021-02-23),

8. 7989599 - Activator including biosurfactant as active ingredient, mannosyl erythritol lipid, and production method thereof (2011-08-02),

Title: The Innovative Contributions of Tomotake Morita

Introduction

Tomotake Morita is a prominent inventor based in Tsukuba, Japan, known for his significant contributions to the field of biotechnology. With seven patents to his name, Morita has focused on advancing environmentally friendly technologies and bioprocesses that have far-reaching implications in various industries.

Latest Patents

Morita's latest innovations include two notable patents. The first is titled "Biosurfactant-producing recombinant microorganism", which outlines a method for increasing the production efficiency of mannosylerythritol lipids (MEL). This invention introduces a transformed microorganism that utilizes an expression vector with a lipase-encoding gene regulated by the E5Pgap promoter or E5Ptef promoter.

The second patent, named "Technique for controlling molecular weight of PHA copolymer produced by halobacterium", aims to provide a polyhydroxyalkanoate (PHA), particularly PHBV, with a molecular weight exceeding 3,610,000. The invention also details a method for producing such a PHA while maintaining control over its molecular weight, utilizing a copolymer derived from random copolymerization of 3-hydroxybutanoic acid and 3-hydroxyvaleric acid.

Career Highlights

Throughout his career, Tomotake Morita has worked with reputable organizations including the National Institute of Advanced Industrial Science and Technology and Kureha Corporation. His research and development efforts have led to innovative solutions and advancements in the biotechnology sector.

Collaborations

Morita has collaborated with esteemed colleagues in his field, including Tokuma Fukuoka and Hironaga Akita. Together with his coworkers, Morita has contributed to the enhancement of biotechnological applications and has worked towards finding sustainable solutions to global challenges.

Conclusion

Tomotake Morita's work continues to inspire advancements in biotechnology through innovative inventions and collaborations. His contributions reflect a commitment to harnessing biological processes for a sustainable future, solidifying his position as a key figure in the realm of modern inventions.

This text is generated by artificial intelligence and may not be accurate.